Abstract Number: 1493 • ACR/ARHP Annual Meeting 2015
Sandra M. Robinson1, Peta S. Heslop1, Stacey Duffy2 and David Walker3, 1R&D, North Tyneside General Hospital, North Shields, United Kingdom, 2R&D, Northumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom, 3Rake Lane, Northumbria Healthcare, Newcastle Upon Tyne, United Kingdom
Background/Purpose: Methotrexate has become the mainstay of DMARD treatment in Rheumatoid Arthritis and is also used in other rheumatological conditions. It is a drug that…